Tag: Quest Diagnostics
New to drug testing: Signature Quest
In 2013, we embarked on a Signature Quest, traveling to conferences and trade shows around the country to collect signatures from attendees.
New to drug testing: Drug Testing Index
The Drug Testing Index has been the industry’s ‘go-to’ report on drug use trends for more than 25 years.
New to Drug Testing: Too small for drug testing? Bloomberg Business Week doesn’t think so
After reading the Bloomberg BusinessWeek article, I sat down with Dr. Sample to ask him a few of my own questions about small business drug testing.
New to drug testing: Complete line of products and services
Our Complete Line of Drug Testing Solutions brochure highlights all of our products & services which can be used to help build a drug testing program.
Gain insights from 25 years of drug testing data
Our webinar features milestones and lessons learned from an unprecedented analysis of more than 125 million urine drug tests from the past 25 years.
New to drug testing: Synthetic marijuana
In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
New to drug testing: Six months in
I’ve had the opportunity to learn a lot about the drug testing industry and I've highlighted some of my favorite experiences over the last 26 weeks.
Name that drug: Semi-synthetic, highly prolific
This edition of name that drug was written by Richard Simpson, Science Director at Quest Diagnostics, and is entitled Semi-synthetic, highly prolific.
New to drug testing: ROI calculator
Our drug testing ROI calculator puts hard numbers around the costs of employee drug use and the savings that a drug testing program can yield.
